BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 19796734)

  • 1. The role of cardiovascular magnetic resonance imaging in heart failure.
    Karamitsos TD; Francis JM; Myerson S; Selvanayagam JB; Neubauer S
    J Am Coll Cardiol; 2009 Oct; 54(15):1407-24. PubMed ID: 19796734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of cardiac magnetic resonance imaging.
    Pilz G; Heer T; Harrer E; Ali E; Hoefling B
    Minerva Cardioangiol; 2009 Jun; 57(3):299-313. PubMed ID: 19513011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cardiovascular magnetic resonance in the evaluation of patients with heart failure.
    Prasad SK; Kotwinski P; Assomul R
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):53-9. PubMed ID: 15038413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of cardiac magnetic resonance imaging: Update 2010.
    Hombach V; Merkle N; Bernhard P; Rasche V; Rottbauer W
    Cardiol J; 2010; 17(6):549-57. PubMed ID: 21154256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular MRI for the assessment of heart failure: focus on clinical management and prognosis.
    Muzzarelli S; Ordovas K; Higgins CB
    J Magn Reson Imaging; 2011 Feb; 33(2):275-86. PubMed ID: 21274968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac magnetic resonance imaging for stage B heart failure.
    Partington SL; Cheng S; Lima JA
    Heart Fail Clin; 2012 Apr; 8(2):179-90. PubMed ID: 22405659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac magnetic resonance imaging for myocarditis and nonischemic cardiomyopathies.
    Wassmuth R
    Minerva Cardioangiol; 2009 Aug; 57(4):511-20. PubMed ID: 19763072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cardiovascular MRI in heart failure and the cardiomyopathies.
    White JA; Patel MR
    Cardiol Clin; 2007 Feb; 25(1):71-95, vi. PubMed ID: 17478241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the ischemic etiology of heart failure by cardiovascular magnetic resonance imaging: diagnostic accuracy of late gadolinium enhancement.
    Casolo G; Minneci S; Manta R; Sulla A; Del Meglio J; Rega L; Gensini G
    Am Heart J; 2006 Jan; 151(1):101-8. PubMed ID: 16368300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of myocardial viability with cardiac magnetic resonance imaging.
    Ozben B; Cinçin AA; Mutlu B
    Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():71-6. PubMed ID: 19028638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.
    Mahrholdt H; Wagner A; Judd RM; Sechtem U; Kim RJ
    Eur Heart J; 2005 Aug; 26(15):1461-74. PubMed ID: 15831557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiomyopathy and cardiac magnetic resonance].
    Locca D; Jeanrenaud X; Schwitter J; Girod G; Monney P; De Palma R; Rizzo E; Prasad SK; Vogt P
    Rev Med Suisse; 2009 Oct; 5(221):2051-7. PubMed ID: 19911692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of MR imaging in the diagnosis of cardiac disease].
    Smith HJ
    Tidsskr Nor Laegeforen; 2004 Feb; 124(4):497-9. PubMed ID: 14983198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR).
    Vöhringer M; Mahrholdt H; Yilmaz A; Sechtem U
    Herz; 2007 Mar; 32(2):129-37. PubMed ID: 17401755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular magnetic resonance imaging for the assessment of right heart involvement in cardiac and pulmonary disease.
    Marcu CB; Beek AM; Van Rossum AC
    Heart Lung Circ; 2006 Dec; 15(6):362-70. PubMed ID: 17045525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CMR examination in heart failure.
    Raman SV; Simonetti OP
    Heart Fail Clin; 2009 Jul; 5(3):283-300, v. PubMed ID: 19564009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of myocardial viability by cardiovascular magnetic resonance.
    Lloyd SG; Gupta H
    Echocardiography; 2005 Feb; 22(2):179-93. PubMed ID: 15693786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed enhancement magnetic resonance imaging in nonischemic myocardial disease.
    Moraes GL; Higgins CB; Ordovas KG
    J Thorac Imaging; 2013 Mar; 28(2):84-92; quiz 93-5. PubMed ID: 23422782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular magnetic resonance imaging in ischemic heart disease.
    von Knobelsdorff-Brenkenhoff F; Schulz-Menger J
    J Magn Reson Imaging; 2012 Jul; 36(1):20-38. PubMed ID: 22696124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial assessment of ventricular morphology and function.
    Grothues F; Braun-Dullaeus R
    Heart Fail Clin; 2009 Jul; 5(3):301-14, v. PubMed ID: 19564010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.